These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 1309834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone and dihydrotestosterone in adult male and female stumptail macaques (Macaca arctoides).
    Rhodes L, Harper J, Uno H, Gaito G, Audette-Arruda J, Kurata S, Berman C, Primka R, Pikounis B.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):991-6. PubMed ID: 7962310
    [Abstract] [Full Text] [Related]

  • 3. The penetration enhancer SEPA augments stimulation of scalp hair growth by topical minoxidil in the balding stumptail macaque.
    Diani AR, Shull KL, Zaya MJ, Brunden MN.
    Skin Pharmacol; 1995 Oct; 8(5):221-8. PubMed ID: 8527153
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P, Iamsumang W, Rojhirunsakool S.
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [Abstract] [Full Text] [Related]

  • 5. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
    Dallob AL, Sadick NS, Unger W, Lipert S, Geissler LA, Gregoire SL, Nguyen HH, Moore EC, Tanaka WK.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):703-6. PubMed ID: 8077349
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J, Sanchez RS, Spencer JR, Yee B, Vaughan ED.
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [Abstract] [Full Text] [Related]

  • 7. Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers.
    Gormley GJ, Stoner E, Rittmaster RS, Gregg H, Thompson DL, Lasseter KC, Vlasses PH, Stein EA.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1136-41. PubMed ID: 2156887
    [Abstract] [Full Text] [Related]

  • 8. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI, Tanaka WK, Wang DZ, Ebel DL, Geissler LA, Dallob A, Hafkin B, Gertz BJ.
    J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
    [Abstract] [Full Text] [Related]

  • 9. The effect of a 5 alpha-reductase inhibitor on androgen physiology in the immature male rat.
    George FW, Johnson L, Wilson JD.
    Endocrinology; 1989 Nov; 125(5):2434-8. PubMed ID: 2551651
    [Abstract] [Full Text] [Related]

  • 10. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.
    Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):524-8. PubMed ID: 8381804
    [Abstract] [Full Text] [Related]

  • 11. Finasteride for benign prostatic hyperplasia.
    Hasinski S, Miller JL, Rose LI.
    Am Fam Physician; 1992 Nov; 46(5):1511-4. PubMed ID: 1279965
    [Abstract] [Full Text] [Related]

  • 12. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E, Açikgöz G, Taştan HB, Köse O, Kurumlu Z.
    Dermatology; 2004 Nov; 209(2):117-25. PubMed ID: 15316165
    [Abstract] [Full Text] [Related]

  • 13. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
    Juniewicz PE, Hoekstra SJ, Lemp BM, Barbolt TA, Devin JA, Gauthier E, Frenette G, Dube JY, Tremblay RR.
    Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [Abstract] [Full Text] [Related]

  • 18. Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
    Schwartz JI, Van Hecken A, De Schepper PJ, De Lepeleire I, Lasseter KC, Shamblen EC, Winchell GA, Constanzer ML, Chavez CM, Wang DZ, Ebel DL, Justice SJ, Gertz BJ.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2942-7. PubMed ID: 8768856
    [Abstract] [Full Text] [Related]

  • 19. Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.
    Rittmaster RS, Lemay A, Zwicker H, Capizzi TP, Winch S, Moore E, Gormley GJ.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):484-8. PubMed ID: 1322427
    [Abstract] [Full Text] [Related]

  • 20. Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition.
    Rhodes L, Primka RL, Berman C, Vergult G, Gabriel M, Pierre-Malice M, Gibelin B.
    Prostate; 1993 Aug; 22(1):43-51. PubMed ID: 8381228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.